Phio Pharmaceuticals (PHIO) EPS (Weighted Average and Diluted) (2021)
Phio Pharmaceuticals' EPS (Weighted Average and Diluted) history spans 1 years, with the latest figure at -$11.65 for Q4 2021.
- For Q4 2021, EPS (Weighted Average and Diluted) changed N/A year-over-year to -$11.65; the TTM value through Dec 2021 reached -$12.45, changed N/A, while the annual FY2024 figure was -$9.08, 80.58% up from the prior year.
- EPS (Weighted Average and Diluted) reached -$11.65 in Q4 2021 per PHIO's latest filing, down from -$0.28 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.2 in Q2 2021 to a low of -$11.65 in Q4 2021.